A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome

Azra Raza, Naomi Galili, Scott E. Smith, John Godwin, Ralph V. Boccia, Han Myint, Daruka Mahadevan, Deborah Mulford, Mark Rarick, Gail L. Brown, Dale Schaar, Stefan Faderl, Rami S. Komrokji, Alan F. List, Mikkael Sekeres

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences